Integrated Multiomics Analysis And Mendelian Randomization Identify Sirt1 As A Pivotal Aging-Associated Gene In Meningioma
Meningiomas are the most common type of benign brain tumor in adults, and their occurrence significantly increases with age. This highlights a crucial link between aging and the development of these tumors. Researchers recently conducted a comprehensive study to understand the molecular mechanisms behind this connection. They used a powerful approach called “multiomics analysis,” which involves looking at different layers of biological information, such as gene activity (transcriptomics) and how genes related to aging behave.
The study pinpointed a specific gene, SIRT1, as a central player in the development of meningiomas. Using a technique called Mendelian randomization, which helps determine cause-and-effect relationships by analyzing genetic variations, they found evidence suggesting that SIRT1 might causally contribute to these tumors. This means that changes in SIRT1 could directly influence whether someone develops a meningioma.
Beyond identifying SIRT1, the research also showed that both aging and problems with the immune system contribute to how meningiomas develop. They observed changes in various immune cells, like B cells and T cells, in tumor tissues compared to healthy ones, and these changes were linked to genes like SIRT1. The findings suggest that SIRT1 could be a valuable tool for diagnosing meningiomas and potentially a target for new treatments, offering fresh insights into how age-related processes drive these tumors.
Source: link to paper